Novartis AG Comprehensive Income Attributable To Owners Of Parent
Novartis AG (NVSEF) reported Comprehensive Income Attributable To Owners Of Parent of $17.97 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent · last filed 2026-02-04
- Novartis AG comprehensive income attributable to owners of parent for the quarter ending 2025-06-30 was $6.03B, a 74.57% increase year-over-year.
- Novartis AG comprehensive income attributable to owners of parent for the quarter ending 2024-06-30 was $3.45B, a 36.21% increase year-over-year.
- Novartis AG comprehensive income attributable to owners of parent for the quarter ending 2023-06-30 was $2.54B, a 128.58% increase year-over-year.
- Novartis AG comprehensive income attributable to owners of parent for the quarter ending 2022-06-30 was $1.11B, a 73.10% decline year-over-year.
| Period end | Comprehensive Income Attributable To Owners Of Parent 3 month | Comprehensive Income Attributable To Owners Of Parent 6 month | Comprehensive Income Attributable To Owners Of Parent 12 month |
|---|---|---|---|
| 2025-12-31 | $17.97B 20-F · filed 2026-02-04 | ||
| 2025-06-30 | $6.03B 6-K · filed 2025-07-17 | $10.67B 6-K · filed 2025-07-17 | |
| 2024-12-31 | $12.53B 20-F · filed 2026-02-04 | ||
| 2024-06-30 | $3.45B 6-K · filed 2025-07-17 | $4.88B 6-K · filed 2025-07-17 | |
| 2023-12-31 | $16.05B 20-F · filed 2026-02-04 | ||
| 2023-06-30 | $2.54B 6-K · filed 2024-07-18 | $5.00B 6-K · filed 2024-07-18 | |
| 2022-12-31 | $6.12B 20-F · filed 2025-01-31 | ||
| 2022-06-30 | $1.11B 6-K · filed 2023-07-18 | $4.77B 6-K · filed 2023-07-18 | |
| 2021-12-31 | $21.53B 20-F · filed 2024-01-31 | ||
| 2021-06-30 | $4.12B 6-K · filed 2022-07-19 | $5.31B 6-K · filed 2022-07-19 | |
| 2020-12-31 | $11.40B 20-F/A · filed 2023-05-15 | ||
| 2020-06-30 | $2.70B 6-K · filed 2021-07-21 | $4.22B 6-K · filed 2021-07-21 | |
| 2019-12-31 | $11.53B 20-F · filed 2022-02-02 | ||
| 2019-06-30 | $6.89B 6-K · filed 2020-07-21 | $7.90B 6-K · filed 2020-07-21 | |
| 2018-12-31 | $12.21B 20-F · filed 2021-01-26 | ||
| 2018-06-30 | $6.63B 6-K · filed 2019-07-18 | $9.94B 6-K · filed 2019-07-18 | |
| 2017-12-31 | $10.54B 20-F · filed 2020-01-29 | ||
| 2017-06-30 | $3.88B 6-K · filed 2018-07-18 | $6.65B 6-K · filed 2018-07-18 | |
| 2016-12-31 | $4.38B 20-F · filed 2019-01-30 | ||
| 2015-12-31 | $15.98B 6-K · filed 2018-01-24 |